CTA-Sticky-button.png clinicaltrialsyearbook+button

3rd Annual Preclinical Development Operations Summit 2018

14th - 15th November, Boston

The second edition of the Preclinical Development Operations Summit was a thought-provoking two days of engaging presentations, discussion and networking.

Chaired by Mr Barnett, Executive Chairman at Lubris Bio, the event focused on how to maximize your business relations with your internal and external collaborators. It included insightful presentations from Olivier Negre, Director of Translational Research, Bluebird Bio and Ajai Chaudhary, Director External Research and External Capabilities, Lead PPDM, Merck.

New FDA regulations in the preclinical space were pinpointed by Karin Zeh, Head of Program Management and Regulatory Operations, Zafgen. Dr Rakesh Dixit, Vice President, Research & Development, MedImmune AstraZeneca, our keynote speaker, addressed challenges to preclinical development of immune-oncology biologics. The event closed on a high note with a panel (including Sean Muthian, Executive Director, External Sciences Innovations, Allergan - Pamela Hill, Open Innovation Program Director, AstraZeneca - Ben Askew, Vice President of Research, SciFluor Life Sciences) discussing site monitoring.

Following on from this success, Arena International is pleased to announce that this unique event will be returning once again in November 2018.

The 2018 program aims to stay abreast of the latest industry trends and operational challenges in preclinical development so if you have an interesting topic proposal, please get in touch with the program director.


Event News

Who should attend this event?

The Preclinical Development Operations Summit is the only strategically focused preclinical development conference in the US.Primary delegates for this event are VP/ Directors/ Heads of:Preclinical ResearchPreclinical DevelopmentIn-vivo PharmacologyProcurementR&DPreclinical SafetyToxicology


Countdown to Preclinical Development Operations Summit 2018